California, Rest In Peace: Pharmaceutical Companies, Keep Your Settlement Discussions Out of California READ MORE
NHK-Fintiv Frustration: Status of the Current Challenges and the Uncertain Fate of the PTAB’s Discretionary Denial of IPRs READ MORE
Haug Partners Secures Dismissal of U.S. Fraudulent Transfer Claims for U.K. Internet Marketing Agency READ MORE
Is Silence Disclosure? The Federal Circuit Clarifies its Position on Negative Claim Limitations READ MORE
AstraZeneca AB v. Mylan Pharms. Inc.: Claim Construction of a Percentage Term Guided by the Written Description and Prosecution History READ MORE
